Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within the existing legal framework by rigorously enforcing the provisions of the Clinical Establishments (Registration and Regulation) Act, 2010.

According to an official communication issued by the Union Ministry of Health and Family Welfare, states have been asked to immediately step up implementation of the Act, which mandates registration, minimum standards for infrastructure, staff, and services, and periodic inspections of all clinical establishments — from small nursing homes to large corporate hospitals.

A key focus of the directive is the introduction and enforcement of standardised package rates for common medical procedures and treatments across hospitals. The Centre has emphasised that uniform pricing will protect patients from arbitrary and inflated bills, especially in cases involving health insurance. This step is expected to curb the practice of overcharging and ensure that patients receive fair and predictable treatment costs irrespective of the hospital they choose.

The communication also highlights the urgent need for stronger grievance redressal mechanisms to resolve disputes involving hospitals, insurance companies, and patients. States have been instructed to set up or strengthen dedicated cells or online portals for timely handling of complaints related to overbilling, denial of insurance claims, quality of care, and unethical practices. The Centre has stressed that these mechanisms should be accessible, transparent, and time-bound to build greater trust in the healthcare ecosystem.

The directive comes amid growing concerns over rising out-of-pocket healthcare expenses and frequent conflicts between stakeholders in the insurance sector. By working strictly within the existing provisions of the Clinical Establishments Act, the government aims to achieve better regulation without requiring new legislation.

All states have been asked to submit action-taken reports within the next two months, detailing steps taken to enforce the Act, implement standardised rates, and operationalise robust grievance redressal systems. The Centre has assured full technical and financial support to states for capacity building and digital infrastructure required for effective implementation.

This initiative is being seen as a major step towards making quality healthcare more affordable and accountable for millions of patients across the country.

Related Posts

ICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026

New Delhi: The Indian Council of Medical Research (ICMR) participated in the national programme ‘विज्ञान–Tech’, organised on the occasion of National Technology Day 2026 at BRIC–National Institute of Immunology (NII), New…

Patient dies after oxygen supply stops in ambulance

Family stages protest outside hospital mortuary, demands action A 20-year-old patient referred from Pali to Jodhpur died in an ambulance after the oxygen supply reportedly stopped midway. Following the incident,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026

ICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026

Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?

Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?

Patient dies after oxygen supply stops in ambulance

Patient dies after oxygen supply stops in ambulance

IndiaAI, ICMR sign MoU to advance AI in healthcare

IndiaAI, ICMR sign MoU to advance AI in healthcare

Illegal drug manufacturing racket busted in Baddi area

Illegal drug manufacturing racket busted in Baddi area

US FDA and Telangana DCA bolster global pharma safety at second regulatory forum

US FDA and Telangana DCA bolster global pharma safety at second regulatory forum